Maas Biolab

Maas Biolab Overview

Founded 1997
Status Private
Employees 4
Latest Deal Type Grant
Latest Deal Amount $2.38M
Latest Deal Amount
Investors 4

Maas Biolab General Information


Operator of a biotechnology firm intended to be used for the development of a neuro-pharmaceutical drug. The company's biotechnology firm is developing a treatment for chronic neurodegenerative diseases including amyotrophic lateral sclerosis, alzheimer's, parkinson's and huntington's, enabling healthcare practitioners to access advanced drugs for better treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 23 Abanico Road
  • Santa Fe, NM 87508
  • United States
+1 (505) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Maas Biolab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2007 $2.38M 0000 Completed Generating Revenue
1. Later Stage VC 25-Apr-2006 0000 0000 Completed Generating Revenue

Maas Biolab Executive Team (3)

Name Title Board Seat Contact Info
Marcus Keep MD Chief Executive Officer & President
Eskil Elmér Founder, Chief Scientific Officer and Director
Michael Vickers Director of Operations

Maas Biolab Board Members (1)

Name Representing Role Since
Cesar Borlongan Ph.D Self Chairman 000 0000

Maas Biolab Investors (4)

To view Maas Biolab‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National institutes of Neurological Disorders and Stroke Corporation 000 0000 000000 0
Small Business Innovation Research Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial